Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-45

First 45 Last

Share
Profile

Follow
sholtz

2,272 Posts.

835

29/11/22

22:00

Post #: 65059178
Share

Originally posted by volvoman: ↑

Well, with respect, it bemuses me that people like you can have no consideration for those of us that got on this wild ride very early and went through endless frustration of crap, after crap, after crap, after crap, with this company, in its various incarnations, evolutions and pursuits.

Gloat about you and your mates because you lucked up and joined at the right time. How easy it is for you to sagely say "you should have averaged down". Spare just a thought for those of us who had to endure "10 years ago" and more, who again and again and again, threw hard earned into what was enthusiastically promoted as "the next big medical thing" but turned out to be, at that time, a money sucking abyss, where the reward each time was actually a cold hard slap in the face.

Coulda and Shoulda are two words that are easy to say, but you can only turn the other financial cheek so many times my friend. What would you have done when your confidence and trust in a company was shot to bits, time after time. Would you just keep shelling out, shelling out and shelling out?

I can see a light on the AVR horizon now and apart from significantly improving lives, I hope it can finally, give us ALL the returns which have been alluded to, like a dangling carrot, for such a long, long, long time.

Rant over. Go drink wine!

V.

Expand

I think the over $700k I was down qualifies me as one of us, don’t you think.

Absolutely no luck involved here, it’s call conviction.

And obviously I kept shelling out when things were at there bleakest, but I believed in the TAVR strategy.

So you won’t find me complaining about the past as I’m thankful we pulled through to be in the strong position we find ourselves in today.

AVR Price at posting: $23.21 Sentiment: Hold Disclosure: Held
15 Upvote

1 Great analysis

Reply

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

First 45 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.91		Change -0.210(3.43%)		Mkt cap ! $91.59M

Open	High	Low	Value	Volume
$6.01	$6.08	$5.85	$44.71K	7.43K

Buyers (Bids)

No.	Vol.	Price($)
1	857	$5.83

Sellers (Offers)

Price($)	Vol.	No.
$6.08	260	1

View Market Depth

No.	Vol.	Price($)
1	857	5.830
1	900	5.780
1	1000	5.610
2	3500	5.600
2	3736	5.500

Price($)	Vol.	No.
6.080	260	1
6.180	50	1
6.200	1000	1
6.400	130	1
6.500	255	1

Last trade - 15.51pm 26/06/2025 (20 minute delay)

AVR (ASX) Chart

Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-45

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-45

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News